AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
Crucell and NIAID to develop Ebola vaccine.(National Institute of Allergy and Infectious Diseases)(Brief Article)
2002 JUN 12 - (NewsRx.com & NewsRx.net) -- Dutch antibody and vaccine company Crucell N.V. (CRXL) announced it has entered into a cooperative research and development agreement with the Vaccine Research Center of the National Institute of Allergy and Infectious Diseases (NIAID) to jointly develop a vaccine against Ebola.
The vaccine will be based on Crucell's proprietary vaccination platform, AdVac. This vaccine will be produced on Crucell's human designer cell line PER.C6. AdVac will be equipped with optimized Ebola genes that have been created by researchers from the NIAID.
AdVac allows for safe and potent vaccines that can be produced in large quantities. The technology builds on a revolutionary adenovirus-based vaccination vector that has been optimized to efficiently present antigens to the human immune system.
...
- Vical's Ebola vaccine shows early promise.(Brief Article)
- Newspaper article from: Pharma Marketletter February 27, 2006 700+ words
...that a Phase I trial of its leading Ebola vaccine candidate shows that the therapeutic...assessment, was sponsored by the National Institute of Allergy and Infectious Diseases...DNA-based products, like its Ebola vaccine.
- Vical and NIH Developing Ebola Vaccine.
- Press release article from: PR Newswire November 18, 2003 700+ words
...Vaccine Research Center (VRC), National Institute of Allergy and Infectious Diseases...safety testing of the investigational Ebola vaccine also began today using clinical supplies...commercialization rights for the VRC's Ebola vaccine as we continue to support its development...
- Crucell says Ebola vaccine effective on monkeys.(News Wire)
- Magazine article from: Healthcare Purchasing News July 1, 2004 700+ words
...biotechnology firm Crucell said that a single dose of its Ebola vaccine has successfully protected monkeys from the deadly disease...months by the Vaccine Research Center (VRC) of the U.S. National Institute of Allergy and Infectious Diseases (NIAID). PER.C6...
- A New Weapon Against Ebola.(vaccine in development)(Brief Article)
- Magazine article from: Newsweek International Guterl, Fred Suterwalla, Shehnaz December 11, 2000 700+ words
...says coauthor Gary J. Nabel, a virologist at the National Institute of Health in Bethesda, Maryland. "Does that tell us...yet, but it tells us we're on the right track." An ebola vaccine is an especially tricky thing to develop because the virus...
- Ebola vaccine works fast in monkey test.(Virus Shield)
- Magazine article from: Science News Seppa, N. August 9, 2003 700+ words
...impressive immunity in monkeys, it took several months to take hold, says Gary J. Nabel, a virologist at the National Institute of Allergy and Infectious Diseases in Bethesda, Md. For the typical Ebola outbreak, that's too slow, he...
- NIH begins human Ebola vaccine trial using Biojector 2000.
- Newspaper article from: Health & Medicine Week January 5, 2004 700+ words
...a developer of needle-free drug delivery systems, announced that the Vaccine Research Center (VRC) at the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. National Institutes of Health, recently began...
- Bioject Announces National Institutes of Health Begins Human Ebola Vaccine...
- Press release article from: PR Newswire December 8, 2003 700+ words
...developer of needle-free drug delivery systems, announced today that the Vaccine Research Center (VRC) at the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, recently began its...
- Bioject Signs Services and Supply Agreement With The National Institutes of...
- Press release article from: PR Newswire June 18, 2003 700+ words
...Under the terms of the agreement, Bioject will supply the government's Vaccine Research Center ("VRC"), National Institute of Allergy and Infectious Diseases/National Institutes of Health ("NIAID/NIH"), with the non-exclusive...
Source: HighBeam Research, Crucell and NIAID to develop Ebola vaccine.(National Institute of...